Detalhe da pesquisa
1.
Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism.
Nephrology (Carlton)
; 25(8): 634-643, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31765028
2.
Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism.
Clin Exp Nephrol
; 22(2): 426-436, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28836058
3.
A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients.
Nephrol Dial Transplant
; 32(10): 1723-1730, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28057872
4.
A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patientsâ©.
Clin Nephrol
; 88(2): 68-78, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28671062
5.
Effects of the Intravenous Calcimimetic Etelcalcetide on Bone Turnover and Serum Fibroblast Growth Factor 23: Post Hoc Analysis of an Open-label Study.
Clin Ther
; 40(12): 2099-2111, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30473399
6.
A Single- and Multiple-Dose, Multicenter Study of Etelcalcetide in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism.
Kidney Int Rep
; 2(4): 634-644, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29142982
7.
Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study.
J Glaucoma
; 25(10): e826-e833, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27300645
8.
EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.
Br J Ophthalmol
; 100(6): 843-7, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26453641
9.
The pharmacological profile and the clinical efficacy of the world's 1st intravenous calcimimetics; etelcalcetide hydrochloride (Parsabiv®).
Nihon Yakurigaku Zasshi
; 150(2): 98-113, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28794306
10.
A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease.
Dement Geriatr Cogn Dis Extra
; 1(1): 163-79, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22163242
11.
[Pharmacological profile and clinical results of the rivastigmine patch as a new therapeutic agent for Alzheimer's disease].
Nihon Yakurigaku Zasshi
; 139(1): 26-32, 2012 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-22230878